Pancreatic Cancer Research

ResearcherSaiseikai Fukuoka General HospitalActive in the last 2 years

Hiroto Tanaka

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-8763-0872; OpenAlex author ID A5103951173. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Neoantigen peptide-pulsed dendritic cell vaccine therapy after surgical treatment of pancreatic cancer: a retrospective study. Co-author DOI 10.3389/fimmu.2025.1571182↗
  2. [A three-week regimen of S-1 monotherapy reduced gastrointestinal toxicity and maintained efficacy in patients with gemcitabine-refractory advanced pancreatic … Co-author PMID 25812499↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chika Iwamoto · 1 shared paper, 2025 · strength 0.20
  2. Masafumi Nakamura · 1 shared paper, 2025 · strength 0.20
  3. Kohei Nakata · 1 shared paper, 2025 · strength 0.20
  4. Toshiya Abe · 1 shared paper, 2025 · strength 0.20
  5. Nao Fujimori · 1 shared paper, 2025 · strength 0.20
  6. Koki Oyama · 1 shared paper, 2025 · strength 0.20
  7. Naoki Ikenaga · 1 shared paper, 2025 · strength 0.20
  8. Takashi Morisaki · 1 shared paper, 2025 · strength 0.20
  9. Hideya Onishi · 1 shared paper, 2025 · strength 0.20
  10. Yusuke Nakamura · 1 shared paper, 2025 · strength 0.20
  11. Shuichi Mitsunaga · 1 shared paper, 2015 · strength 0.04
  12. Masafumi Ikeda · 1 shared paper, 2015 · strength 0.04
  13. Hideki Ueno · 1 shared paper, 2015 · strength 0.04
  14. Takuji Okusaka · 1 shared paper, 2015 · strength 0.04
  15. Atsushi Ochiai · 1 shared paper, 2015 · strength 0.04
  16. Chigusa Morizane · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.